Featured Research

from universities, journals, and other organizations

Researchers Begin Promising New Trial To Fight Colorectal Cancer

Date:
March 12, 2004
Source:
New York University Medical Center And School Of Medicine
Summary:
New York University School of Medicine investigators are leading a national study, called TREE-2, which will evaluate the safety and efficacy of three regimens of Eloxatin plus fluoropymidine, plus Avastin as first-line treatment of patients with advanced colorectal cancer.

NEW YORK, March 10, 2004 – New York University School of Medicine investigators are leading a national study, called TREE-2, which will evaluate the safety and efficacy of three regimens of Eloxatin™ plus fluoropymidine, plus Avastin™ as first-line treatment of patients with advanced colorectal cancer. Two hundred and ten patients will be enrolled at 80 sites in the United States.

This new study is based on promising data presented at the 2003 American Society of Clinical Oncology (ASCO) meeting demonstrating an incremental survival benefit when Avastin™ was added to a standard first-line colon cancer treatment regimen called IFL (Irinotecan, 5-FU, Leucovorin). At the same meeting, it was reported that patients treated with Eloxatin, used in combination with the fluoropymidine 5-FU (FOLFOX), survived longer than those treated with IFL in a head-to-head comparison study. Eloxatin? is manufactured by Sanofy-Synthelabo and Genentech manufactures Avastin?.

"The findings from this study have the potential to affect the standard of care for metastatic colorectal cancer," said Howard Hochster, M.D, lead investigator of the TREE 2 study. "We are making focused efforts to find the most effective therapeutic option currently available for treatment of colorectal cancer. This study will combine an effective anti-angiogenesis antibody with the best possible chemotherapy. We are also looking at ways of making the oxaliplatin-based chemotherapy regimens more user friendly for the patient."

It is hoped that this new drug regimen will ultimately improve the treatment and survival rate of patients with colorectal cancer, the second leading cause of cancer deaths in the United States. Approximately 150,000 new cases are diagnosed each year and in 2003 nearly 60,000 deaths were attributed to the disease.


Story Source:

The above story is based on materials provided by New York University Medical Center And School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

New York University Medical Center And School Of Medicine. "Researchers Begin Promising New Trial To Fight Colorectal Cancer." ScienceDaily. ScienceDaily, 12 March 2004. <www.sciencedaily.com/releases/2004/03/040311071225.htm>.
New York University Medical Center And School Of Medicine. (2004, March 12). Researchers Begin Promising New Trial To Fight Colorectal Cancer. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2004/03/040311071225.htm
New York University Medical Center And School Of Medicine. "Researchers Begin Promising New Trial To Fight Colorectal Cancer." ScienceDaily. www.sciencedaily.com/releases/2004/03/040311071225.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Predicting Heart Transplant Rejection With a Blood Test

Predicting Heart Transplant Rejection With a Blood Test

Ivanhoe (Aug. 27, 2014) Now a new approach to rejection of donor organs could change the way doctors predict transplant rejection…without expensive, invasive procedures. Video provided by Ivanhoe
Powered by NewsLook.com
Better Braces That Vibrate

Better Braces That Vibrate

Ivanhoe (Aug. 27, 2014) The length of time you have to keep your braces on could be cut in half thanks to a new device that speeds up the process. Video provided by Ivanhoe
Powered by NewsLook.com
Smartphone App Tracks Your Heart Rate

Smartphone App Tracks Your Heart Rate

Ivanhoe (Aug. 27, 2014) A new app that can track your heart rate 24/7 is available for download in your app store and its convenience could save your life. Video provided by Ivanhoe
Powered by NewsLook.com
Stroke in Young Adults

Stroke in Young Adults

Ivanhoe (Aug. 27, 2014) A stroke can happen at any time and affect anyone regardless of age. This mother chose to give her son independence and continue to live a normal life after he had a stroke at 18 years old. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins